FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The Peptide Craze Ground Truths BPC 157 LIVE ALPHA LABS In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few FDA moves toward easing restrictions on certain peptides BioPharma Dive